scPharmaceuticals Inc. Common Stock
Symbol: SCPH (NASDAQ)
0.00
▼ (-100.00%) -5.610
Company Description:
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $5.61
- Yesterday High: $5.635
- Yesterday Low: $5.61
- Yesterday Volume: 846.41K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: scPharmaceuticals Inc. Common Stock
- Website: https://www.scpharmaceuticals.com
- Listed Date: 2017-11-17
- Location: BURLINGTON, MA
- Market Status: Active
- CIK Number: 0001604950
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $301.14M
- Round Lot: 100
- Outstanding Shares: 53.68M
- Asset Type: CS
RECENT FILINGS FOR SCPH
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | SCHEDULE 13G | View |
| 2025-09-08 | SC 14D9 | View |
| 2025-09-08 | SC TO-T | View |
| 2025-08-25 | SC TO-C | View |
| 2025-08-25 | SC14D9C | View |
| 2025-08-25 | SC TO-C | View |
| 2025-08-25 | SC14D9C | View |
| 2025-08-25 | 8-K | View |
| 2025-08-25 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-21 | SCHEDULE 13G/A | View |
| 2025-06-09 | 8-K | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
| 2025-06-05 | 4 | View |
Latest News on SCPH